Watch NHTC. Know when insiders buy.
One email the day a filing lands. Free.
NHTC
NATURAL HEALTH TRENDS CORP
1.05
−0.12 −10.26%
USD · close Sep 23
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
10
FLAG · shorts 10
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $9MP/E —DIV YIELD 66.67%FCF YIELD -82.66%REV TTM $38.2M −10.5%NET INCOME −$1.2M −328.9%NET CASH —52W 1.05 – 4.62SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2026 · Mar 31 | $9.2M | −14.3% | 75.0% | −$474K | −$154K | −226.2% | -0.02 | −$797K | $115K | −$912K | Apr 29 |
| Q4 2025 · Dec 31 | $9.7M | −10.1% | 72.9% | −$635K | −$588K | −434.1% | -0.05 | −$959K | $5K | −$964K | Feb 20 |
| Q3 2025 · Sep 30 | $9.5M | −11.4% | 73.7% | −$495K | −$431K | −1331.4% | -0.04 | $113K | $43K | $70K | Feb 20 |
| Q2 2025 · Jun 30 | $9.8M | −6.3% | 73.9% | −$333K | $15K | −91.3% | 0.00 | −$5.6M | $4K | −$5.6M | Feb 20 |
| Q1 2025 · Mar 31 | $10.7M | −2.0% | 73.6% | −$345K | $122K | −35.1% | 0.01 | $484K | $16K | $468K | Apr 29 |
| Q4 2024 · Dec 31 | $10.8M | −0.8% | 74.2% | −$421K | $176K | −50.8% | 0.02 | $88K | $20K | $68K | Feb 20 |
| Q3 2024 · Sep 30 | $10.7M | +0.7% | 74.1% | −$275K | $35K | −79.7% | 0.00 | −$436K | $7K | −$443K | Feb 20 |
| Q2 2024 · Jun 30 | $10.5M | −0.3% | 74.2% | −$238K | $173K | — | 0.02 | −$3.6M | $19K | −$3.6M | Feb 20 |
| Q1 2024 · Mar 31 | $11M | — | 73.4% | −$365K | $188K | — | 0.02 | $549K | $11K | $538K | Feb 20 |
| Q4 2023 · Dec 31 | $10.9M | — | 74.5% | −$242K | $358K | — | 0.03 | −$69K | $14K | −$83K | Feb 21 |
| Q3 2023 · Sep 30 | $10.6M | — | 74.7% | −$292K | $172K | — | 0.02 | −$869K | $18K | −$887K | Feb 21 |
| Q2 2023 · Jun 30 | $10.5M | — | 74.6% | −$743K | −$219K | — | -0.02 | −$2.6M | $7K | −$2.7M | Feb 21 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $39.8M | 73.5% | −$1.8M | −$882K | -2.2% | -0.08 | −$6M | $68K | −$6.1M | — | $9.2M |
| FY2024 · to Dec 31 | $43M | 74.0% | −$1.3M | $572K | 1.3% | 0.05 | −$3.4M | $57K | −$3.4M | — | $9.2M |
| FY2023 · to Dec 31 | $43.9M | 74.6% | −$1.7M | $568K | 1.3% | 0.05 | −$4.3M | $46K | −$4.3M | — | $9.2M |
| FY2022 · to Dec 31 | $49.1M | 74.2% | −$270K | $313K | 0.6% | 0.03 | −$4.9M | $143K | −$5M | — | $9.1M |
| FY2021 · to Dec 31 | $60M | 75.0% | $1.6M | $1.1M | 1.8% | 0.09 | $1M | $225K | $791K | — | $9.1M |
| FY2020 · to Dec 31 | $62.1M | 72.6% | $669K | $843K | 1.4% | 0.07 | $1.9M | $211K | $1.7M | $0 | $9.1M |
Every number comes from NATURAL HEALTH TRENDS CORP's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.